Share on LinkedInShare on LinkedIn

ARTICLE · 19 JULY 2017

Post-BMS Personal Jurisdiction Is Pretty Straightforward

We commented last week that we were not surprised by the numerous post-BMS personal jurisdiction decisions we were seeing.

United StatesLitigation, Mediation & Arbitration

We commented last week that we were not surprised by the numerous post-BMS personal jurisdiction decisions we were seeing. Lots of courts and parties around the country were watching and waiting for this one. So, let's add some more. This time from another of plaintiffs' favorite "magnet jurisdictions" – Missouri. Historically, product liability plaintiffs bringing pharmaceutical and medical device cases have flocked to Missouri (the City of St. Louis in particular) among other notoriously plaintiff-friendly venues as litigation tourists. They would file multi-plaintiff complaints against drug and device companies not located in Missouri, including at least 1 Missouri plaintiff – to tie the case to the state — and at least 1 plaintiff from defendant's home state – to destroy diversity.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from